Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

Share Price is delayed by 15 minutes
Get Live Data
2,658.00    55.00 (2.11%)
Bid:
2,659.00
Ask:
2,660.00
Spread: 1.00 (0.038%)
Market Cap: £26.72b
III Live PriceLast checked at - London Stock Exchange

Intraday 3i Group Share Chart

Directorate Change

24 Oct 2018 09:14

RNS Number : 0179F
3i Group PLC
24 October 2018
 

 

3i Group plc: non-executive Director appointment

 

Coline McConville

3i Group plc announces the appointment of Coline McConville as a non-executive Director with effect from 1 November 2018.

 

Coline McConville is currently a non-executive director of Fevertree Drinks plc, Inchcape plc and Travis Perkins plc. She is also a member of the Supervisory Board of Tui AG. She was previously a non-executive director of Tui Travel plc, UTV Media plc, Wembley National Stadium Limited, Shed Media plc and HBOS plc.

 

Prior to that Coline was Chief Operating Officer and Chief Executive Officer Europe of Clear Channel International Limited and had previously worked for McKinsey.

 

Simon Thompson, 3i Chairman, said: "We are very pleased to announce Coline's appointment to 3i's Board. She brings extensive commercial experience in a variety of sectors and significant board experience."

 

Coline McConville commented: "I am very pleased to be joining 3i as the firm continues to focus on successfully executing its strategic plan. 3i has a strong management team, a strong institutional franchise and is well placed to continue to generate value for its shareholders."

 

There are no further matters to be disclosed in accordance with paragraph 9.6.13R of the UKLA's Listing Rules.

 

 

-Ends-

 

For further information, contact:

Kathryn van der Kroft 020 7975 3021

Communications Director

 

Silvia Santoro 020 7975 3258

Investor Relations Director

 

Notes to Editors:

 

About 3i

 

3i is a leading international investment manager focused on mid-market private equity and infrastructure. Its core investment markets are northern Europe and North America. For further information, please visit: www.3i.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAMIBPTMBBTMBP
Date   Source Headline
29th May 20183:49 pmRNSDoc re. 2018 Annual Report and Accounts
25th May 201810:32 amRNSDirector Declaration
18th May 20181:29 pmRNSDirector/PDMR Shareholding
18th May 201811:56 amRNSDirector/PDMR Shareholding
17th May 20187:00 amRNSFinal Results
30th Apr 20184:11 pmRNSTotal Voting Rights
30th Apr 20184:07 pmRNSDirector/PDMR Shareholding
4th Apr 201810:11 amRNSPortfolio Update
29th Mar 20182:02 pmRNSTotal Voting Rights
29th Mar 20181:59 pmRNSDirector/PDMR Shareholding
9th Mar 20188:30 amRNSAction refinancing and Capital Markets seminar
28th Feb 20183:44 pmRNSTotal Voting Rights
28th Feb 20183:44 pmRNSDirector/PDMR Shareholding
1st Feb 20183:51 pmRNSDirector/PDMR Shareholding
1st Feb 20187:00 amRNSFY2018 Q3 performance update
31st Jan 20184:17 pmRNSTotal Voting Rights
31st Jan 20184:16 pmRNSDirector/PDMR Shareholding
2nd Jan 20184:15 pmRNSPortfolio Update
19th Dec 20173:18 pmRNSTotal Voting Rights
19th Dec 20173:15 pmRNSDirector/PDMR Shareholding
12th Dec 20173:05 pmRNSBlock listing Interim Review
6th Dec 201711:13 amRNSDirector/PDMR Shareholding
5th Dec 201712:00 pmRNSDirector/PDMR Shareholding
4th Dec 201710:32 amRNSDirector Declaration
30th Nov 20173:29 pmRNSTotal Voting Rights
30th Nov 20173:28 pmRNSDirector/PDMR Shareholding
16th Nov 201712:19 pmRNSDoc re. Half Yearly Report 2017
16th Nov 20177:00 amRNS3i Group Half-year results to 30 September 2017
31st Oct 20173:54 pmRNSDirector/PDMR Shareholding
31st Oct 20173:53 pmRNSTotal Voting Rights
3rd Oct 201712:37 pmRNSPortfolio Update
29th Sep 20173:51 pmRNSTotal Voting Rights
29th Sep 20173:50 pmRNSDirector/PDMR Shareholding
18th Sep 20178:30 amRNSPrivate Equity Capital Markets Seminar
31st Aug 20173:48 pmRNSTotal Voting Rights
31st Aug 20173:46 pmRNSDirector/PDMR Shareholding
31st Jul 20174:41 pmRNSTotal Voting Rights
31st Jul 20174:36 pmRNSDirector/PDMR Shareholding
28th Jul 20174:12 pmRNSDirector/PDMR Shareholding
26th Jul 20173:14 pmRNSDirector/PDMR Shareholding
26th Jul 20177:00 amRNSQ1 Performance update
6th Jul 20173:24 pmRNSPortfolio Update
30th Jun 20174:28 pmRNSDirector/PDMR Shareholding
30th Jun 20173:18 pmRNSTotal Voting Rights
30th Jun 20173:17 pmRNSDirector/PDMR Shareholding
29th Jun 20172:54 pmRNSResult of AGM
29th Jun 20172:35 pmRNSDoc re. AGM Resolutions
29th Jun 20172:25 pmRNSDirector/PDMR Shareholding
19th Jun 20174:19 pmRNSDTR 6.3.5
13th Jun 201711:26 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.